News >

COA Highlights Concern Over Growing Influence of PBMs

Tony Hagen @oncobiz
Published: Friday, Apr 28, 2017

Josh Cox, PharmD, BCPS

Josh Cox, PharmD, BCPS

The influence of Pharmacy Benefit Managers (PBMs) on prescription drug pricing and availability has continued to frustrate members of the Community Oncology Alliance (COA). An April report from COA stated that PBMs have been calling patients and urging them to get their drugs from PBM-owned pharmacy networks, rather than through physician dispensaries. At this year’s Community Oncology Conference, held in April in Oxon Hill, Maryland, presentations and discussions focused on this report, which also described instances of patients receiving drugs late, putting their health in jeopardy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x